Philippe Jay

Dr. Philippe Jay


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2016 in Nature
Verified
Journal Article
Closed access
PDF file
FGFrançois Gerbe
François Gerbe
ESEmmanuelle Sidot
Emmanuelle Sidot
DSDanielle J. Smyth
Danielle J. Smyth
MOMakoto Ohmoto
Makoto Ohmoto
IMIchiro Matsumoto
Ichiro Matsumoto
PJPhilippe Jay
Philippe Jay

1 November 1996 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ERErich Roessler
Erich Roessler
EBElena Belloni
Elena Belloni
KGKarin Gaudenz
Karin Gaudenz
PJPhilippe Jay
Philippe Jay
PBPhilippe Berta
Philippe Berta
MMMaximilian Muenke
Maximilian Muenke

5 December 1997 in Science
Verified
Journal Article
Closed access
PDF file
CCChan D. Chung
Chan D. Chung
JLJiayu Liao
Jiayu Liao
BLBin Liu
Bin Liu
XRXiaoping Rao
Xiaoping Rao
PJPhilippe Jay
Philippe Jay
KSKe Shuai
Ke Shuai
The signal transducer and activator of transcription–3 (Stat3) protein is activated by the interleukin 6 (IL-6) family of cytokines, epidermal growth factor, and leptin. A protein named PIAS3 (protein inhibitor of activated STAT) that binds to Stat3 was isolated and characterized. The association of PIAS3 with Stat3 in vivo was only observed in cells stimulated with ligands that cause the activation of Stat3. PIAS3 blocked the DNA-binding activity of Stat3 and inhibited Stat3-mediated gene activation. Although Stat1 is also phosphorylated in response to IL-6, PIAS3 did not interact with Stat1 or affect its DNA-binding or transcriptional activity. The results indicate that PIAS3 is a specific inhibitor of Stat3.

20 March 2005 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
JEJohan H. van Es
Johan H. van Es
PJPhilippe Jay
Philippe Jay
AGAlex Gregorieff
Alex Gregorieff
MGMarielle E. van Gijn
Marielle E. van Gijn
SJSuzanne Jonkheer
Suzanne Jonkheer
HCHans Clevers
Hans Clevers

13 August 2007 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
PBPauline Bastide
Pauline Bastide
Charbel DaridoCharbel Darido
Charbel Darido
JPJulie Pannequin
Julie Pannequin
RKRalf Kist
Ralf Kist
SRSylvie Robine
Sylvie Robine
PJPhilippe Jay
Philippe Jay
The HMG-box transcription factor Sox9 is expressed in the intestinal epithelium, specifically, in stem/progenitor cells and in Paneth cells. Sox9 expression requires an active β-catenin–Tcf complex, the transcriptional effector of the Wnt pathway. This pathway is critical for numerous aspects of the intestinal epithelium physiopathology, but processes that specify the cell response to such multipotential signals still remain to be identified. We inactivated the Sox9 gene in the intestinal epithelium to analyze its physiological function. Sox9 inactivation affected differentiation throughout the intestinal epithelium, with a disappearance of Paneth cells and a decrease of the goblet cell lineage. Additionally, the morphology of the colon epithelium was severely altered. We detected general hyperplasia and local crypt dysplasia in the intestine, and Wnt pathway target genes were up-regulated. These results highlight the central position of Sox9 as both a transcriptional target and a regulator of the Wnt pathway in the regulation of intestinal epithelium homeostasis.

5 July 2004 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
PBPhilippe Blache
Philippe Blache
MWMarc van de Wetering
Marc van de Wetering
IDIsabelle Duluc
Isabelle Duluc
CDClaire Domon
Claire Domon
PBPhilippe Berta
Philippe Berta
PJPhilippe Jay
Philippe Jay
TCF and SOX proteins belong to the high mobility group box transcription factor family. Whereas TCFs, the transcriptional effectors of the Wnt pathway, have been widely implicated in the development, homeostasis and disease of the intestine epithelium, little is known about the function of the SOX proteins in this tissue. Here, we identified SOX9 in a SOX expression screening in the mouse fetal intestine. We report that the SOX9 protein is expressed in the intestinal epithelium in a pattern characteristic of Wnt targets. We provide in vitro and in vivo evidence that a bipartite β-catenin/TCF4 transcription factor, the effector of the Wnt signaling pathway, is required for SOX9 expression in epithelial cells. Finally, in colon epithelium-derived cells, SOX9 transcriptionally represses the CDX2 and MUC2 genes, normally expressed in the mature villus cells of the intestinal epithelium, and may therefore contribute to the Wnt-dependent maintenance of a progenitor cell phenotype.